4D Molecular Therapeutics
FDMT
FDMT
111 hedge funds and large institutions have $892M invested in 4D Molecular Therapeutics in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 19
1% more funds holding
Funds holding: 110 → 111 (+1)
32% less call options, than puts
Call options by funds: $3.07M | Put options by funds: $4.51M
Holders
111
Holding in Top 10
2
Calls
$3.07M
Puts
$4.51M
Top Buyers
| 1 | +$33.9M | |
| 2 | +$13.3M | |
| 3 | +$9.55M | |
| 4 |
VA
VR Adviser
New York
|
+$8.59M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$7.6M |
Top Sellers
| 1 | -$10M | |
| 2 | -$8.27M | |
| 3 | -$5.96M | |
| 4 |
Millennium Management
New York
|
-$4.22M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.91M |